Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Acadia Healthcare Company (ACHC) EPS (Weighted Average and Diluted) (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with -$12.98 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 3705.56% to -$12.98 in Q4 2025 year-over-year; TTM through Dec 2025 was -$12.16, a 537.41% decrease, with the full-year FY2025 number at -$12.16, down 537.41% from a year prior.
  • EPS (Weighted Average and Diluted) was -$12.98 for Q4 2025 at Acadia Healthcare Company, down from $0.4 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.88 in Q2 2022 to a low of -$12.98 in Q4 2025.
  • A 5-year average of -$0.23 and a median of $0.64 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 509.09% in 2022, then tumbled 3705.56% in 2025.
  • Acadia Healthcare Company's EPS (Weighted Average and Diluted) stood at $0.63 in 2021, then rose by 3.17% to $0.65 in 2022, then dropped by 3.08% to $0.63 in 2023, then crashed by 42.86% to $0.36 in 2024, then crashed by 3705.56% to -$12.98 in 2025.
  • Per Business Quant, the three most recent readings for ACHC's EPS (Weighted Average and Diluted) are -$12.98 (Q4 2025), $0.4 (Q3 2025), and $0.33 (Q2 2025).